# Viromed Medical signs EUR 152.5M distribution deal with UMECO Group for Asia

Viromed Medical AG and UMECO Group signed an exclusive five-year distribution agreement for cold plasma medical devices ViroCAP and PulmoPlas in ten Asian countries. The deal is valued at EUR 152.5 million, including a USD 5 million license fee and purchase commitments through 2028.

- Type: Contract
- Announced: 2025-04-01
- Where: Malta
- Value: $165.0M (152.5M EUR)
- Status: announced
- Products: ViroCAP cold plasma device, PulmoPlas cold plasma device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Viromed Medical AG](https://endata.com/companies/83861.md)
- [UMECO Group](https://endata.com/companies/83862.md) (partner)
- [Landsberg First Class Aesthetic](https://endata.com/companies/84360.md) (customer)

## Sources

- [ad-hoc-news.de](https://www.ad-hoc-news.de/boerse/ueberblick/viromed-medical-ag-umeco-group-erwirbt-exklusive-vermarktungsrechte-fuer/66973790), 2025-04-01: "Umeco erwirbt die exklusiven Marketing- und Vertriebsrechte für ViroCAP® und PulmoPlas® zur kosmetischen und medizinischen Behandlung von dermatologischen und pneumologischen Infektionen in Korea, Taiwan, Thailand, Indonesien, Japan, Shanghai, Philippinen, Singapur, Malaysia und Vietnam."
- [eqs-news.com](https://www.eqs-news.com/news/corporate/exclusive-contract-for-virocap-my-plasma-with-landsberg-first-class-aesthetic-opens-up-viromeds-entry-into-the-european-cosmetics-market/5c9e4396-0e26-49df-bd85-2dbc73077911_en), 2025-04-25: "Landsberg opens up entry into the European cosmetics market for Viromed."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.